Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Evolent Health Inc
EVH | US
3.13
USD0.18
6.10%
EVH | US
About Evolent Health Inc
Sector
Healthcare
Industry
Health Information Services
Earnings date
30/06/2024
As of date
24/04/2026
Close
3.13
Open
2.96
High
3.13
Low
2.88
Evolent Health Inc. a healthcare company through its subsidiary Evolent Health LLC offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services such as health plan services risk management analytics and reporting and leadership and management; and Identifi a proprietary technology system that aggregates and analyzes data manages care workflows and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care independent of their stage of maturation and specific market dynamics in oncology cardiology and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington Virginia.
View LessEVH | US
Risk
89.2
Sharpe
-0.93
Luna's Score
43/100
Recommendation
Sell
Luna says (EVH | US)
What's Working
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
102.2%1 month
89.2%3 months
89.8%6 months
80.3%Returns
Fundamental Ratios
PE
-
Fwd. PE
14.04
Price to book
2.75
Debt to equity
0.78
Debt to assets
0.33
Ent. to EBITDA
52.14
Ent. to rev.
1.46
PEG
-1.37
Other Fundamentals
EBITDA
136.26M
MarketCap
363.99M
MarketCap(USD)
363.99M
Div. yield
-
Op. margin
1.46
Erngs. growth
-
Rev. growth
37.90
Ret. on equity
-5.94
Short ratio
8.06
Short perc.
12.27
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
1.41
Range1M
1.57
Range3M
1.96
Volumes: Market Activity
Rel. volume
0.44
Price X volume
3.79M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 52.14 | - | Expensive |
| Ent. to Revenue | 1.46 | - | Cheaper |
| PE Ratio | - | 64.03 | - |
| Price to Book | 2.75 | 6.17 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 89.79 | - | Riskier |
| Debt to Equity | 0.78 | 0.44 | Expensive |
| Debt to Assets | 0.33 | 0.35 | Par |
| Market Cap | 363.99M | - | Emerging |
